¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"specific fertility rate"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • adjusted death rate
    Á¶Á¤»ç¸Á·ü
  • abortion rate
    À¯»êÀ²
  • absorbed dose rate
    Èí¼ö¼±·®·ü
  • alveolar ventilation rate
    ÆóÆ÷ȯ±âÀ², ÇãÆÄ²Ê¸®È¯±âÀ²
  • basal metabolic rate
    ±âÃÊ´ë»çÀ²
  • bed turnover rate
    º´»óȸÀüÀ²
  • bacterial growth rate
    ¼¼±ÕÁõ½Ä·ü
  • birth rate
    Ãâ»ý·ü
  • blood flow rate
    1. Ç÷·ù·® 2. Ç÷·ù¼Óµµ
  • completion rate
    ¿Ï¼º·ü
  • concordance rate
    ÀÏÄ¡À²
  • conversion rate
    ÀüȯÀ²
  • corrected death rate
    Á¤Á¤»ç¸Á·ü
  • cardiac rate
    ½ÉÀå¹Úµ¿¼ö
  • crude birth rate
    º¸ÅëÃâ»ý·ü, Á¶Ãâ»ý·ü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • specific gravity test
    ºñÁß½ÃÇè
  • specific soluble substance
    ƯÀ̰¡¿ë¹°Áú
  • virus-specific
    ¹ÙÀÌ·¯½ºÆ¯ÀÌ-
  • abortion rate
    À¯»êÀ²
  • absorbed dose rate
    Èí¼ö¼±·®·ü
  • actual death rate
    ½ÇÁ¦»ç¸Á·ü
  • adjusted death rate
    (¢¡standardized death rate) Ç¥ÁØÈ­»ç¸Á·ü
  • air kerma-rate constant
    °ø±âÄ¿¸¶À²»ó¼ö
  • alveolar ventilation rate
    ÇãÆÄ²Ê¸®È¯±âÀ², ÆóÆ÷ȯ±âºñ
  • arterial perfusion rate
    µ¿¸Æ°ü·ùÀ²
  • attack rate
    ¹ßº´·ü
  • bacterial growth rate
    ¼¼±ÕÁõ½Ä·ü
  • basal metabolic rate
    ±âÃÊ´ë»çÀ²
  • bed turnover rate
    º´»óȸÀüÀ²
  • birth rate
    Ãâ»ý·ü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • infant mortality rate
    ¿µ¾Æ»ç¸Á·ü.
  • plasma iron disappearance rate
    Ç÷Àåö¼Ò½Ç·ü(úìíìôÑá¼ã÷ëÒ).
  • plasma iron turnover rate
    Ç÷Àåö±³Ã¼À².
  • postneonatal mortality rate
    ÈĽŻý¾Æ»ç¸Á·ü(Ì·ËàË×ËâË×ËÎËô).
  • pregnancy rate
    ÀÓ½ÅÀ²(ìôããëÒ).
  • prevalence [rate]
    À¯º´·ü
  • prevalence rate
    À¯º´·ü(ËôËÓËô).
  • production rate
    »ý»êÀ²
  • puerperal death rate
    »ê¿å»ç¸Á·ü (ÊÙË×ËÎËô).
  • puerperal death rate
    »êÈÄ»ç¸Á·ü,»ê¿å»ç¸Á·ü (¡­ÞÝØÌëÒ)
  • pulse rate
    ÆÞ½ºÀ²
  • pulse repetition rate
    ÆÞ½º ¹Ýº¹À²
  • rate
    ¼Óµµ
  • rate dependent bundle branch block
    ½É¹Ú¼öÀÇÁ¸¼º °¢Â÷´Ü.
  • rate limiting
    ¼ÓµµÁ¦ÇÑÀÇ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • specific activity
    ƯÀÌȰ¼º[µµ], ºñ[Ýï]Ȱ¼º[µµ]
  • specific activity
    ºñ¹æ»ç´É
  • specific adhesion
    °íÀ¯Á¢Âø(ͳêóïÈó·).
  • specific antagonist
    ƯÀÌÀû ±æÇ×Á¦(÷åì¶îÜÑÏù÷ð¥).
  • specific antigen, organ
    Àå±âƯÀÌÇ׿ø
  • specific blood group substance
    ƯÀÌÇ÷¾×Çü¹°Áú(¡­úìäûúþÚªòõ).
  • specific blood group substance
    ƯÀÌÇ÷¾×Çü¹°Áú(¡­úìäûúþÚªòõ)
  • specific blood group substance
    ƯÀÌÇ÷¾×Çü¹°Áú(?Ì´ËâÌ´?̤).
  • specific capsular reaction
    ƯÀÌÇù¸·¹ÝÀÀ (¡­úõدÚãëë).
  • specific capsular reaction
    ƯÀÌÇù¸·¹ÝÀÀ (¡­úõدÚãëë).
  • specific cellular immunity
    ƯÀÌÀû ¼¼Æ÷¸é¿ª (¡­îÜá¬øàØóæ¹).
  • specific cellular immunity
    ƯÀÌÀû ¼¼Æ÷¸é¿ª (¡­îÜá¬øàØóæ¹).
  • specific charge
    ºñÀüÇÏ(Ýïï³ùÃ).
  • specific compliance
    ƯÀÌÀÀ¶ô(¡­ëëÕ«).
  • specific conductivity
    ºñÀüµµÀ²(ÝïîîÓôëÒ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
FF degree of fineness of abrasive particles; fat-free; father factor; fecal frequency; fertility factor...
ff+ fertility inhibition positive
ff- fertility inhibition negative
FRF Fertility Research Foundation; follicle-stimulating hormone-releasing factor
IBIDS ichthyosis-brittle hair-impaired intelligence-decreased fertility-short stature [syndrome]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
GPI-PLC Glycosyl phosphatidylinositol-specific phospholipase C
GPI-PLD Glycosyl-phosphatidylinositol-specific phospholipase D
GC Group Specific Component
gs Group-specific
GSA Group-specific antigen
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • mutation rate
    º¯ÀÌÀ², µ¹¿¬º¯ÀÌÀ²
  • neonatal mortality rate
    ½Å»ý¾Æ »ç¸Á·ü
  • operative mortality rate
    ¼ö¼ú »ç¸Á·ü
  • overall rate
    ÃÑüÀû ºñÀ²
  • peak flow rate
    ÃÖ´ë À¯¼Ó, ÃÖ°í À¯¼Ó
  • prevalance rate
    À¯º´À²
  • prevalence rate
    À¯º´·ü
  • processing rate
    ½Ã¼ú È¿À²
  • rate dependent bundle branch block
    ½É¹Ú ¼ö ÀÇÁ¸¼º °¢ Â÷´Ü
  • rate of ablation
    Á¦°ÅÀ²
  • rate of polymerization
    ÁßÇÕ·ü
  • rate of teeth decayed
    ¿ì½Ä·ü
  • rate-limiting enzyme
    ¼Óµµ Á¶Àý È¿¼Ò
  • repetition rate
    ¹Ýº¹À²
  • respiratory rate
    È£ÈíÀ²
    ¼ºÀÎÀÇ °æ¿ì È£ÈíÀº 1ºÐ¿¡ 16~18ȸ ¾î¸°ÀÌ´Â 24~28ȸ Á¤µµ°¡ Á¤»óÀÌ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
specific immune globulin Globulin fraction of pooled serums (or plasma) selected for high titre of antibodies specific for a particular antigen, or from persons specifically immunised.
(05 Mar 2000)
specific immunity The immune status in which there is an altered reactivity directed solely against the antigenic determinants (infectious agent or other) that stimulated it.
See: acquired immunity.
(05 Mar 2000)
specific ionisation <radiobiology> The number of ion pairs formed per unit of distance along the track of an ion passing through matter
(16 Dec 1997)
specific optical dispersion <microscopy> The difference between the refractive indices of light of two different wavelengths, both indices measured at the same temperature, the difference being divided by the specific gravity also measured in the same medium at the test temperature. For convenience, the specific dispersion value is multiplied by ten.
(05 Aug 1998)
specific parasite A parasite that habitually lives in its present host and is particularly adapted for the host species.
(05 Mar 2000)
specific passive immunity See: acquired immunity.
(05 Mar 2000)
specific pathogen-free organisms Animals or humans raised in the absence of a particular disease-causing virus or other microorganism. Less frequently plants are cultivated pathogen-free.
(12 Dec 1998)
specific reaction The phenomena produced by an agent that is identical with or immunologically related to the one that has already caused an alteration in capacity of the tissue to react.
(05 Mar 2000)
specific serum A monovalent antiserum, i.e., one obtained by inoculating an animal with one antigen or species or strain of bacteria.
(05 Mar 2000)
specific soluble polysaccharide A soluble type-specific polysaccharide produced during active growth of virulent pneumococci composing a large part of the capsule.
Synonym: pneumococcal polysaccharide, soluble specific substance, specific soluble polysaccharide, specific soluble sugar.
(05 Mar 2000)
specific soluble sugar A soluble type-specific polysaccharide produced during active growth of virulent pneumococci composing a large part of the capsule.
Synonym: pneumococcal polysaccharide, soluble specific substance, specific soluble polysaccharide, specific soluble sugar.
(05 Mar 2000)
specific therapy Therapy aimed at the cause(s) of a disease process, as opposed to symptomatic therapy.
(05 Mar 2000)
specific transduction Transduction in which the bacteriophage strain is able to transfer only some, or only one, of the donor bacterium genes.
Synonym: specific transduction.
(05 Mar 2000)
specific urethritis An obsolete term for gonorrhoea.
(05 Mar 2000)
N(2),N(2)-dimethylguanosine-specific tRNA methyltransferase <enzyme> Responsible for the modification of both mitochondrial and cytoplasmic trnas
Registry number: EC 2.1.1.-
Synonym: dmg trna methyltransferase
(26 Jun 1999)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á